The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We here describe the construction of the Stockholm CREAtinine Measurement (SCREAM) cohort and assess its coverage/representativeness of the Stockholm county in Sweden. SCREAM has the principal aims to estimate the burden and consequences of chronic kidney disease (CKD) and to identify inappropriate drug use (prescription of nephrotoxic, contraindicated or ill-dosed drugs). METHODS: SCREAM is a repository of laboratory data of individuals, residing or accessing healthcare in the region of Stockholm, who underwent creatinine assessments between 2006-11. Laboratory tests were linked to administrative databases with complete information on socioeconomic status, demographic data, healthcare utilization, diagnoses, vital status and dispensed prescription medicines. RESULTS: SCREAM identified 1 118 507 adult Stockholm citizens with available creatinine tests between 2006-11. This corresponded to 66% of the complete population in the region. Geographical coverage was uniform, ranging between 62 and 72% throughout its 26 municipalities. Population coverage was higher across older age strata (50% coverage for age range 18-44 years, >75% for 45-64 years and >90% coverage for ≥65 years). Of note, 97 and 98% of all individuals with a diagnosis of diabetes mellitus or cardiovascular disease, respectively, were captured by SCREAM. Further, 89% of all deaths registered in the period occurred in individuals with a creatinine test undertaken. CONCLUSION: SCREAM represents the largest cohort to estimate the burden and healthcare implications of CKD in Sweden. The coverage and representativeness of the region of Stockholm was high and in accordance to both the commonness of creatinine assessment, and the medical indications for creatinine testing. The inclusion of individuals who sought medical care and had a creatinine test undertaken resulted in a slight over-representation of elderly and comorbid patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383 · cited 2×
“The development of simple creatinine-based equations to estimate kidney function has contributed to raise the epidemics of chronic kidney disease (CKD) to the category of major public health problem [1].”
Background(2010) · The Lancet · doi:10.1016/s0140-6736(10)60674-5 · Cited by 4,200 · cited 1×
“CKD is an important contributor to the burden of non-communicable diseases, leading to poor quality of life and severely reduced life expectancy [2].”
BackgroundWettermark, B., Hammar, N., MichaelFored, C., Leimanis, A., Otterblad Olausson, P., Bergman, U., Persson, I., Sundström, A., Westerholm, B., & Rosén, M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1294 · Cited by 1,887
Self-citation
Cited by
Existing Data Sources in Clinical Epidemiology: Laboratory Information System Databases in Denmark
Arendt, J. F. H., Hansen, A. T., Ladefoged, S. A., Sørensen, H. T., Pedersen, L., & Adelborg, K. (2020) · Clinical Epidemiology · doi:10.2147/clep.s245060 · Cited by 292
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
Nilsson, E., Gasparini, A., Ärnlöv, J., Xu, H., Henriksson, K. M., Coresh, J., Grams, M. E., & Carrero, J. J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.035 · Cited by 211
Self-citationBandak, G., Sang, Y., Gasparini, A., Chang, A. R., Ballew, S. H., Evans, M., Arnlov, J., Lund, L. H., Inker, L. A., Coresh, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005428 · Cited by 181
“International Classification of Disease—Tenth Edition (ICD-10) diagnostic codes as previously described.(16) Medications assessed included diuretics (both loop and thiazide), nonsteroidal anti-inflammatory drugs, spironolactone, b-blockers, and other antihypertension medications.”
Self-citationAssociation Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease
Klatte, D. C. F., Gasparini, A., Xu, H., de Deco, P., Trevisan, M., Johansson, A. L. V., Wettermark, B., Ärnlöv, J., Janmaat, C. J., Lindholm, B., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.046 · Cited by 163
Self-citationCarrero, J. J., Andersson Franko, M., Obergfell, A., Gabrielsen, A., & Jernberg, T. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012638 · Cited by 161
“Because plasma creatinine is routinely ordered during the characterization and follow-up of patients with MI, the Stockholm Creatinine Measurements healthcare-use cohort was estimated to capture the virtually complete (99% coverage) population with MI of the region.(14) Laboratory data were linked with regional and na…”
MethodSelf-citation
Metadata
- Authors
- Runesson, B., Gasparini, A., Qureshi, A. R., Norin, O., Evans, M., Barany, P., Wettermark, B., Elinder, C. G., & Carrero, J. J.
- Venue
- Clinical Kidney Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-14
- Volume
- 9
- Issue
- 1
- Pages
- 119-127
- ISSN
- 2048-8505 (ISSN-L)
- 2048-8513
- OpenAlex
- W2174316937
- Cited by
- 96
- References
- 4
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.